T. ROWE PRICE HEALTH SCIENCES FUND, INC. (CIK 1002624) is an SEC-registered fund company with 1 reporting fund series and $10.9B in net assets as of 2026-03-31.
| Series | Net assets |
|---|---|
| T. Rowe Price Health Sciences Fund, Inc. | $10.9B |
| Holding | Value |
|---|---|
| ELI LILLY & CO | $1.1B |
| THERMO FISHER SCIENTIFIC INC | $442.9M |
| INTUITIVE SURGICAL INC | $397.9M |
| STRYKER CORP | $377.1M |
| MERCK & CO. INC. | $374.9M |
| ASTRAZENECA PLC | $345.4M |
| UNITEDHEALTH GROUP INC | $336.3M |
| ARGENX SE - ADR | $317.9M |
| ABBVIE INC | $309.6M |
| REGENERON PHARMACEUTICALS | $288.4M |
| GILEAD SCIENCES INC | $283.6M |
| JOHNSON & JOHNSON | $266.0M |
| VERTEX PHARMACEUTICALS INC | $264.0M |
| DANAHER CORP | $222.9M |
| ALNYLAM PHARMACEUTICALS INC | $176.0M |